Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Always Active
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

No cookies to display.

Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

No cookies to display.

Skip to main content
search

24 July 2023 – An amicus brief was filed with the Supreme Court Of The United States (SCOTUS) on behalf of members of the electronic nicotine delivery systems (ENDS) industry in support of petitioners in Loper Bright Enterprises v Raimondo on the question of whether to overturn or limit Chevron deference

What is Chevron Deference?

Chevron deference is applicable in the interpretation of statutes (laws). It is based on the belief that expert agencies are better suited than federal judges to make policy choices that Congress left open. SCOTUS articulated a two-part test for applying the Chevron deference:

  1. They examine the wording and context of the statute in question to see whether Congress’s intent is clear. If it is, the agency must follow the letter of the law.
  2. If the statutory language is not clear – meaning it has two or more reasonable interpretations – the reviewing court must defer to the agency’s choice in how to interpret and carry out the law.

Why Overrule/Limit Chevron Deference?

Chevron deference allows agencies to reach beyond the limits of a statute’s plain language and makes it more difficult to challenge an agency’s action in court.

Were SCOTUS to overrule/limit Chevron’s deference, businesses, organisations, and individuals could more successfully challenge administrative actions in court.

How Has the Chevron Deference Affected the ENDS Industry?

ENDS products are subject to the US Food and Drug Administration (FDA). Most courts reviewing challenges to premarket application denials of ENDS products use the FDA’s interpretation of the Family Smoking Prevention and Tobacco Control Act (TCA) and the Appropriate Protection of the Public Health (APPH) standard.

The effect of this FDA interpretation has been a de facto ban on non-tobacco flavoured ENDS products.

Although the plain language of the TCA requires the FDA to review each premarket tobacco product application (PMTA) individually and balance numerous factors in deciding whether a particular product is APPH, their application of Chevron deference has resulted in marketing denial orders (MDOs) of more than a million non-tobacco flavoured products, venturing far beyond the TCA’s plain language and goals (one of which is to promote the development and marketing of lower-risk tobacco products).

Where To From Here?

SCOTUS limited the case to the question of whether Chevron doctrine should be limited or overruled. Oral arguments will be scheduled for the 2023 Fall term.

Read more about advocacy and get involved with the cause to help save lives in tobacco harm reduction.
Keen to stop smoking? Improve your quality of life.

Read more on tobaccoharmreduction.net

Follow us

THR IN PAN AMERICA

Related Posts

Pan American Harm reduction AllianceTobacco Harm ReductionParadigm Shift Needed In Pan America’s Approach to End Smoking
2 June 2023

Paradigm Shift Needed In Pan America’s Approach to End Smoking

World No Tobacco Day serves as an important reminder of the harmful effects of cigarette smoking and the need for…
Tobacco Harm Reduction Seminar in BrazilTobacco Harm ReductionTobacco Harm Reduction Seminar in Brazil
9 June 2023

Tobacco Harm Reduction Seminar in Brazil

The South American Seminar on Tobacco Harm Reduction (THR), held in São Paulo on 11 May 2023, saw experienced speakers from fields…
Flavours contribute to cessation success | Dr K FarsalinosTobacco Harm ReductionVapingSystematic Review of Vaping Flavours | Dr. Konstantinos Farsalinos
14 July 2023

Systematic Review of Vaping Flavours | Dr. Konstantinos Farsalinos

Following the South American Seminar on Tobacco Harm Reduction (THR), held in São Paulo, we were joined by a panel…
Alcohol Harm Reduction

More about

Alcohol Harm Reduction

Drug Harm Reduction

More about

Drug Harm Reduction